uniQure to Participate in Multiple Upcoming Industry Conferences in October

Rhea-AI Summary

uniQure N.V. (NASDAQ: QURE) announced its participation in several upcoming investor and scientific conferences. Key events include Chardan’s 5th Annual Genetic Medicines Conference on October 4-5, 2021, featuring a fireside chat with CEO Matt Kapusta. Other conferences include the Cell & Gene Meeting on the Mesa (October 12-14), where Joshua Leeman will present, and the ESGCT meeting (October 19-22) for preclinical data presentations. The Jefferies Gene Therapy/Editing Summit will take place on October 27-28, with another fireside chat featuring Kapusta.

LEXINGTON, Mass. and AMSTERDAM, Sept. 30, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences:

• Chardan’s 5^th Annual Genetic Medicines Conference, October 4 - 5, 2021
  
  
  • Members of uniQure’s management team, including Matt Kapusta, chief executive officer, will participate in virtual one-on-one investor meetings the morning of Tuesday, October 5^th.
    
    
  • A fireside chat with Matt Kapusta will take place the same day from 8:00 to 8:30 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website.
    
    
• Alliance for Regenerative Medicine: Cell & Gene Meeting on the Mesa, October 12 - 14, 2021
  
  
  • Joshua Leeman, Ph.D., VP, Search & Evaluation, Business Development, will be making a corporate presentation on Wednesday, October 13^th at 12:15 p.m. PDT.
    
    
  • Dr. Leeman will also be participating in a panel entitled, “Delivering the Innovation of Gene Therapy to Patients Through Strategic Collaborations Workshop” on Thursday, October 14^th starting at 7:15 a.m. PDT.
    
    
• European Society of Gene and Cell Therapy (ESGCT), October 19 – 22. 2021
  
  
  • uniQure will present multiple preclinical data presentations at the meeting. Specific details to follow when the meeting abstracts are released.
    
    
• Jefferies Gene Therapy/Editing Summit, October 27 - 28, 2021
  
  
  • Members of uniQure’s management team including Ricardo Dolmetsch, Ph.D., president of Research & Development, will participate virtually in one-on-one investor meetings throughout the day on Thursday, October 28^th.
    
    
  • A fireside chat with Matt Kapusta will take place the same day from 12:00 to 12:30 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website.
    

About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with severe genetic diseases of the central nervous system (CNS) and liver, including clinical programs in hemophilia B and Huntington's disease and preclinical candidates in Fabry disease, spinocerebellar ataxia Type 3, temporal lobe epilepsy, Alzheimer’s, Parkinson’s, and ALS. www.uniQure.com

uniQure Contacts:
FOR INVESTORS:				FOR MEDIA:
Maria E. Cantor		Chiara Russo		Tom Malone
Direct: 339-970-7536		Direct: 617-306-9137		Direct: 339-970-7558
m.cantor@uniQure.com		c.russo@uniQure.com		t.malone@uniQure.com

FAQ

What conferences is uniQure participating in October 2021?

uniQure is participating in Chardan’s 5th Annual Genetic Medicines Conference, the Cell & Gene Meeting on the Mesa, the ESGCT meeting, and the Jefferies Gene Therapy/Editing Summit.

Who will present at the Cell & Gene Meeting on the Mesa?

Joshua Leeman, Ph.D., will make a corporate presentation at the Cell & Gene Meeting on the Mesa on October 13, 2021.

What is the date of the Chardan’s 5th Annual Genetic Medicines Conference?

Chardan’s 5th Annual Genetic Medicines Conference will be held on October 4-5, 2021.

When will uniQure's CEO participate in investor meetings?

Matt Kapusta, CEO of uniQure, will participate in investor meetings on October 5, 2021, during Chardan’s conference.

What type of presentations will uniQure present at the ESGCT meeting?

uniQure will present multiple preclinical data presentations at the ESGCT meeting from October 19-22, 2021.

When will the Jefferies Gene Therapy/Editing Summit take place?

The Jefferies Gene Therapy/Editing Summit is scheduled for October 27-28, 2021.